Talcum Powder Products Linked to Ovarian Cancer
Long-term use of talcum powder is linked to an increased risk of ovarian cancer. As early as 1971, scientific studies have shown a strong correlation between ovarian cancer and regular use of talcum powder in the genital area. Despite the fact that there have been suspicions in the medical community about the safety of talcum powder for decades, Johnson & Johnson chose not to add warning labels to any of their talcum powder products.
Products such as Johnson’s Baby Powder® and Shower to Shower® are cornerstones of the Johnson and Johnson brand. These products have helped J&J launch a baby product division which is currently worth nearly $2 billion. Manufacturer Johnson & Johnson knew of the potential health risks of talcum powder for years but failed to add warning labels to these products for fear of tarnishing their brand.
By choosing not to add warning labels to their Johnson’s Baby Powder® and Shower to Shower® products, J&J put the health and safety of thousands of women at risk. If you or a loved one regularly used Johnson and Johnson talcum powder products and developed ovarian cancer, you may be entitled to file a claim against J&J.
Scientific Studies Link Talcum Powder Use to Ovarian Cancer
Talcum powder is found in many common household products used for feminine hygiene purposes. However, scientific studies indicate that the talc particles in these products can migrate through the fallopian tubes into the ovaries, causing inflammation that can eventually lead to ovarian cancer.
Talc particles were observed in cancerous ovarian tissue as early as 1971. Since then, dozens of studies have pointed to a strong link between regular use of talcum powder and an increased risk of ovarian cancer among women.
The first case-control study linking regular talc use to ovarian cancer was published in 1982. A 2016 study confirmed that genital talc use was associated with an increased risk of ovarian cancer. Dr. Daniel W. Cramer of Harvard University, the leading author of the 2016 study, testified in court in 2013 that he believes regular talc use could a contributing factor in as many as 10,000 ovarian cancer cases every year.
Johnson & Johnson Facing Lawsuits Over Talcum Powder Products
Thousands of women have come forward to seek damages against J&J for their failure to warn consumers about the potential health risks of their talcum powder products. J&J has lost multiple landmark talcum powder cases where plaintiffs were awarded millions in damages.
August 2017, a Los Angeles jury ordered Johnson & Johnson to pay $417 million to a woman suffering from ovarian cancer linked to the use of baby powder.
May 2017, a Missouri jury awarded $110 million to a Virginia woman.
In October 2016, a third jury in Saint Louis awarded more than $70 million in damages to a 62-year-old California woman. The woman claimed her diagnosis of ovarian cancer as a result of her regular use of Johnson & Johnson talcum powder.
May 2016, a second St. Louis jury awarded $55 million in damages to another woman who was a long-term J&J talc user and developed ovarian cancer.
February 2016, a jury in St. Louis awarded $72 million in damages to the estate of a woman who died of ovarian cancer following regular genital talc use.
In all of these cases, juries found a clear link between regular use of talcum powder on the genital area and ovarian cancer. Now, more than 1,200 lawsuits are now pending against J&J for their failure to warn women about the health risks of long-term genital talcum powder use.